Home › NDC Lookup › RxCUI directory › RxCUI 242969

4 ML norepinephrine 1 MG/ML Injection — RxCUI 242969

RxNorm drug concept · Semantic clinical drug
RxCUI 242969 Semantic clinical drug · SCD ● Current RxNorm concept 27 FDA products 30 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI242969
Official name4 ML norepinephrine 1 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnorepinephrine 4 MG per 4 ML Injection; norepinephrine bitartrate 4 MG in 4 mL Injection; norepinephrine (as bitartrate) 4 MG per 4 ML Injection
FDA products mapped27
Package NDCs mapped30
Reported Medicaid activity (SDUD)58 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Norepinephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It raises blood pressure when it has dropped dangerously low, such as in severe, sudden hypotension. It is given in a hospital setting. Some older product labels also list use as a...
  • It is given through an IV drip into a large vein by trained staff. Your team adjusts the rate to your blood pressure and lowers it slowly when it's time to stop.
  • The most common ones are high blood pressure, slow heart rate, anxiety, headache and trouble breathing. Tell your nurse right away about pain, swelling or skin changes at the IV si...
  • Yes. MAO inhibitors, linezolid and tricyclic antidepressants can cause severe, prolonged high blood pressure. It can also raise blood sugar, so diabetes medicines may need adjustin...
📖 Read our full Norepinephrine guide →

🕸️ Concept Web — How 4 ML norepinephrine 1 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 4 ML norepinephrine 1 MG/ML Injection RxCUI 242969

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Norepinephrine 7512
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Levophed 227559
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Norepinephrine Injection 1745276
    • Norepinephrine Injectable Product 1159845
    • Norepinephrine Injection [Levophed] 1745278
    • Levophed Injectable Product 1167947
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Norepinephrine 1 MG/ML SCDC · 328853
  • Norepinephrine Injection SCDF · 1745276
  • Norepinephrine Injectable Product SCDG · 1159845

Brand-Name Concepts

📦 FDA Products & Package NDCs

27 products · 30 package NDCs
30 package NDCs map to RxCUI 242969 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9318-10 10 VIAL in 1 CARTON (0143-9318-10) / 4 mL in 1 VIAL (0143-9... Norepinephrine Bitartrate Hikma Pharmaceuticals USA Inc. 2018-08-01
00409-0161-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-0161-10) / 4 mL in 1... LEVOPHED Hospira, Inc. 2024-03-11
00409-3375-04 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3375-04) / 4 mL in 1... LEVOPHED Hospira, Inc. 2009-04-27
00781-3755-95 10 VIAL, SINGLE-DOSE in 1 CARTON (0781-3755-95) / 4 mL in 1... NOREPINEPHRINE BITARTRATE Sandoz Inc 2019-04-23
25021-0316-04 10 VIAL in 1 CARTON (25021-316-04) / 4 mL in 1 VIAL Norepinephrine Bitartrate Sagent Pharmaceuticals 2021-07-01
31722-0372-32 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-372-32) / 4 mL in 1... Norepinephrine bitartrate Camber Pharmaceuticals, Inc. 2025-01-31
43066-0997-10 10 VIAL, SINGLE-DOSE in 1 CARTON (43066-997-10) / 4 mL in 1... Norepinephrine Bitartrate Baxter Healthcare Company 2021-05-06
47335-0615-44 10 VIAL, SINGLE-DOSE in 1 CARTON (47335-615-44) / 4 mL in 1... NOREPINEPHRINE BITARTRATE Sun Pharmaceutical Industries, Inc. 2021-07-01
51662-1315-01 4 mL in 1 VIAL, SINGLE-DOSE (51662-1315-1) LEVOPHED(R) NOREPINEPHRINE BITARTRATE HF Acquisition Co LLC, DBA HealthFirst 2018-10-18
51662-1315-03 10 POUCH in 1 CASE (51662-1315-3) / 1 mL in 1 POUCH (51662-... LEVOPHED(R) NOREPINEPHRINE BITARTRATE HF Acquisition Co LLC, DBA HealthFirst 2020-09-26
51662-1528-01 4 mL in 1 VIAL (51662-1528-1) NOREPINEPHRINE BITARTRATE HF Acquisition Co LLC, DBA HealthFirst 2021-08-08
51662-1528-03 10 POUCH in 1 CASE (51662-1528-3) / 1 VIAL in 1 POUCH (5166... NOREPINEPHRINE BITARTRATE HF Acquisition Co LLC, DBA HealthFirst 2022-07-10
51991-0983-17 10 VIAL, SINGLE-DOSE in 1 CARTON (51991-983-17) / 4 mL in 1... Norepinephrine Bitartrate Breckenridge Pharmaceutical, Inc. 2021-07-01
63323-0940-04 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-940-04) / 4 mL in 1... Norepinephrine Bitartrate Fresenius Kabi USA, LLC 2021-03-01
64980-0630-41 10 VIAL, SINGLE-DOSE in 1 CARTON (64980-630-41) / 4 mL in 1... Norepinephrine Bitartrate Rising Pharma Holdings, Inc. 2024-11-01
65145-0133-10 10 VIAL, SINGLE-DOSE in 1 CARTON (65145-133-10) / 4 mL in 1... NOREPINEPHRINE BITARTRATE Caplin Steriles Limited 2024-09-28
65219-0140-04 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-140-04) / 4 mL in 1... Norepinephrine Bitartrate Fresenius Kabi USA, LLC 2021-03-01
67457-0852-04 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-852-04) / 4 mL in 1... Norepinephrine bitartrate Mylan Institutional LLC 2018-10-15
68083-0437-10 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-437-10) / 4 mL in 1... Norepinephrine bitartrate Gland Pharma Limited 2021-05-12
70121-1576-07 10 VIAL in 1 CARTON (70121-1576-7) / 4 mL in 1 VIAL (70121-... Norepinephrine Bitartrate Amneal Pharmaceuticals LLC 2018-12-17
70377-0121-12 10 VIAL, SINGLE-DOSE in 1 CARTON (70377-121-12) / 4 mL in 1... NOREPINEPHRINE BITARTRATE BIOCON PHARMA INC. 2025-07-01
71288-0439-05 10 VIAL, SINGLE-USE in 1 CARTON (71288-439-05) / 4 mL in 1... Norepinephrine Bitartrate Meitheal Pharmaceuticals Inc. 2024-12-01
71839-0143-10 10 VIAL, SINGLE-DOSE in 1 CARTON (71839-143-10) / 4 mL in 1... Norepinephrine Bitartrate BE Pharmaceuticals Inc. 2023-12-30
71839-0143-25 25 VIAL, SINGLE-DOSE in 1 CARTON (71839-143-25) / 4 mL in 1... Norepinephrine Bitartrate BE Pharmaceuticals Inc. 2023-12-30
72078-0002-04 10 VIAL, SINGLE-DOSE in 1 CARTON (72078-002-04) / 4 mL in 1... Norepinephrine bitartrate Mylan Institutional LLC 2020-12-04
72205-0241-07 10 VIAL in 1 CARTON (72205-241-07) / 4 mL in 1 VIAL norepinephrine bitartrate Novadoz Pharmaceuticals LLC 2025-12-11
72572-0481-10 10 VIAL, SINGLE-DOSE in 1 CARTON (72572-481-10) / 4 mL in 1... NOREPINEPHRINE BITARTRATE Civica, Inc. 2021-03-12
72603-0180-10 10 VIAL, SINGLE-DOSE in 1 CARTON (72603-180-10) / 4 mL in 1... NOREPINEPHRINE BITARTRATE NorthStar Rx LLC 2023-12-01
83634-0307-04 10 VIAL, SINGLE-DOSE in 1 CARTON (83634-307-04) / 4 mL in 1... norepinephrine bitartrate Avenacy, LLC 2026-02-01
83854-0017-10 10 VIAL in 1 CARTON (83854-017-10) / 4 mL in 1 VIAL (83854-... NOREPINEPHRINE BITARTRATE Anthea Pharma Private Limited 2025-11-25
Observed labelers: HF Acquisition Co LLC, DBA HealthFirst (4) · BE Pharmaceuticals Inc. (2) · Fresenius Kabi USA, LLC (2) · Hospira, Inc. (2) · Mylan Institutional LLC (2) · Amneal Pharmaceuticals LLC (1) · +17 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.